http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105503799-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbd6afe8bf92cebfc1a738927809ab36
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-90
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-90
filingDate 2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c7ed8b6fc7001101bff015f880b7b92
publicationDate 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105503799-A
titleOfInvention Synthesis method of talosalate drug intermediate 2-acetoxybenzoic acid-3-hydroxyphthalide ester
abstract A synthesis method of talosalate drug intermediate 2-acetoxybenzoic acid-3-hydroxyphthalide ester comprises steps as follows: 0.24 mol of acetylsalicylic acid (2), 0.24-0.27 mol of 3-aminophthalide (3), 30-40 ml of isopropyl alcohol and 230-260 ml of cyclohexane are added to a reaction container provided with a stirrer and a reflux condenser, the stirring speed is controlled within 130-160 rpm, reflux is performed for 4-6 h, cyclohexane is evaporated out under the normal pressure, solids are evaporated out through reduced pressure distillation, washed with a salt solution, subjected to suction filtration and recrystallized with ethyl acetate, and white 2-acetoxybenzoic acid-3-hydroxyphthalide ester solids (1) are obtained, wherein the mass fraction of isopropyl alcohol in the step is 65%-70%, and the mass fraction of cyclohexane in the step is 45%-50%.
priorityDate 2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421921999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID478666
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ91VR8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451816491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448736812
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID424957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546985
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8WUW1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68558
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID460916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20239715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415740728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419528643
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449808
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6885
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280833
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3827
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16644
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID288001

Total number of triples: 45.